These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1064461)

  • 1. Conception and congenital abnormalities after chemotherapy of acute myelogenous leukaemia in two men.
    Russell JA; Powles RL; Oliver RT
    Br Med J; 1976 Jun; 1(6024):1508. PubMed ID: 1064461
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of drugs in cutaneous eruptions after chemotherapy for acute myelogenous leukemia.
    Mansouri S; Dubertret L; Bastuji-Garin S; Dombret H; Roujeau JC; Aractingi S
    Arch Dermatol; 1998 Jul; 134(7):881-2. PubMed ID: 9681363
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of acute myelogenous leukaemia.
    Marie JP; Zittoun R
    Baillieres Clin Haematol; 1991 Jan; 4(1):97-113. PubMed ID: 2039863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute leukemia and pregnancy].
    Sosa Muñoz JL; Pérez Santana MT; Sosa Sánchez R; Labardini JR
    Rev Invest Clin; 1983; 35(1):55-8. PubMed ID: 6575413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute myelogenous leukaemia: prognostic value of infectious complications observed during the induction treatment (author's transl)].
    Reiffers J; Vezon G; Broustet A
    Sem Hop; 1981 Jan 18-25; 57(3-4):133-7. PubMed ID: 6261351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation induction therapy of acute myelogenous leukaemias.
    Hassan HT
    Haematologia (Budap); 1988; 21(3):141-50. PubMed ID: 3053358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute myelogenous leukemia and myelodysplastic syndrome after treatment with cytostatic agents].
    Abrahamsen AF
    Tidsskr Nor Laegeforen; 2000 Sep; 120(21):2542-5. PubMed ID: 11070993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conception and congenital abnormalities after chemotherapy for leukaemia.
    Barkhan P; Evans PR
    Br Med J; 1976 Oct; 2(6039):816-7. PubMed ID: 1067887
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of acute myelogenous leukaemia in adults. A retrospective study of 70 patients (1968-1973).
    Willemze R; Hartgrink-Groeneveld CA; Speck B; Eernisse JG
    Neth J Med; 1975; 18(1):17-28. PubMed ID: 1055303
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecular targeting therapy for leukemia].
    Miyazaki Y
    Gan To Kagaku Ryoho; 2010 May; 37(5):806-10. PubMed ID: 20524248
    [No Abstract]   [Full Text] [Related]  

  • 11. Acute esophageal stricture after induction chemotherapy for acute leukemia.
    Kim HK
    Am J Hematol; 1996 Aug; 52(4):335-6. PubMed ID: 8701966
    [No Abstract]   [Full Text] [Related]  

  • 12. Two cases of acute leukaemia in pregnancy.
    O'Donnell R; Costigan C; O'Connell LG
    Acta Haematol; 1979; 61(5):298-300. PubMed ID: 111459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophilic eccrine hidradenitis unassociated with chemotherapy in a patient with acute myelogenous leukemia.
    Roustan G; Salas C; Cabrera R; Simón A
    Int J Dermatol; 2001 Feb; 40(2):144-7. PubMed ID: 11328400
    [No Abstract]   [Full Text] [Related]  

  • 14. Intensive chemotherapy of acute leukaemias in adults. Preliminary communication.
    Maj S; Pawelski S
    Mater Med Pol; 1978; 10(1):75-8. PubMed ID: 273714
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report.
    Belotti A; Doni E; Elli E; Rossi V; Pioltelli P; Pogliani EM
    Acta Haematol; 2011; 126(1):52-3. PubMed ID: 21454967
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of chemotherapy courses on the rate of bloodstream infections during neutropenia in adult acute myeloid leukaemia.
    Kinnunen U; Koistinen P; Ohtonen P; Koskela M; Syrjälä H
    Scand J Infect Dis; 2008; 40(8):642-7. PubMed ID: 18979602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of response and prediction of response to chemotherapy in acute myelogenous leukemia.
    Preisler HD
    Baillieres Clin Haematol; 1991 Jan; 4(1):69-96. PubMed ID: 2039862
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of mutant IDH1 in acute myeloid leukaemia.
    Yaqub F
    Lancet Oncol; 2015 Jan; 16(1):e9. PubMed ID: 25638561
    [No Abstract]   [Full Text] [Related]  

  • 19. Testicular relapse in acute myelogenous leukaemia after 3 1/2 years of complete remission.
    Russo A; Vasquez E; Russo G; Schilirò G
    Acta Haematol; 1981; 65(2):131-3. PubMed ID: 6785960
    [No Abstract]   [Full Text] [Related]  

  • 20. Extramedullary deposits in acute myelogenous leukaemia.
    Jaiprakash MP; Antia PK; Shetty PA
    Indian J Cancer; 1981 Mar; 18(1):51-3. PubMed ID: 6943124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.